HIF1A and rectal cancer: However, despite Kawai et al identifying ALODA (a downstream target of HIF-1α) as an independent prognostic factor for colorectal cancer, it is unlikely that a single target would improve hypoxia-induced radiosensitivity in patients with rectal cancer [38].